Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,739 | Dovepress* | 16,104+ | 1,233 | 17,337 | |
| PubMed Central* | 1,635 | 423 | 2,058 | ||
| Totals | 17,739 | 1,656 | 19,395 | ||
| *Since 24 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 1 | 1 | 2 |
View citations on PubMed Central and Google Scholar